From a global point of view, chronic haematogenous osteomyelitis in children remains a major cause of musculoskeletal morbidity. We have reviewed the literature with the aim of estimating the scale of the problem and summarising the existing research, including that from our institution. We have highlighted areas where well-conducted research might improve our understanding of this condition and its treatment.
From a global point of view, chronic haematogenous osteomyelitis in children remains a major cause of musculoskeletal morbidity. We have reviewed the literature with the aim of estimating the scale of the problem and summarising the existing research, including that from our institution. We have highlighted areas where well-conducted research might improve our understanding of this condition and its treatment.
Chronic haematogenous osteomyelitis in children was once a condition familiar to all orthopaedic surgeons, but it is now rarely seen by surgeons practising in the West. However, it remains a major cause of morbidity and disability in children living in developing countries. Despite this, it is the subject of little research and few publications in the medical literature. Surgeons in western countries may see increasing numbers of children with this condition as a result of migration between developing and developed countries.
Our aim in this article was to consider the scale of the problem, summarise the existing research, including that from our institution, and to highlight areas where well-conducted research might improve the care of children with this condition.
Incidence and prevalence
Chronic haematogenous osteomyelitis in children is now rare in industrialised nations, 1 but continues to be a significant cause of morbidity globally. No accurate data on the incidence and prevalence exists, but there are a number of studies that illustrate indirectly the extent of the disease. The incidence of septic arthritis in a district of Malawi has been estimated as 1 in 5000 per year in those aged under five and 1 in 13 000 in those aged between five and 15 years. 2 The incidence of osteomyelitis is estimated to be half that of septic arthritis in children under two years, but the incidences are approximately equal by the age of two. 3 A recent survey of the orthopaedic needs of children in Rwanda suggested that 3% were suffering from a musculoskeletal impairment due to infection. 4, 5 Nearly two billion children under the age of 18 live in developing countries, and 400 million in the least-developed countries, compared to only 200 million in industrialised countries. 6 If the prevalence of musculoskeletal impairment due to infection across the leastdeveloped countries is similar to that in Rwanda, in these countries alone approximately 12 million children are affected.
Chronic osteomyelitis places a significant burden on the health services available in developing countries. In a review of paediatric surgical services at the main government referral hospital in Banjul, Gambia, osteomyelitis accounted for 7.8% of paediatric surgical admissions and 15.4% of total in-patient days. 7 An audit of surgical activity in Malawi revealed that, nationally, 3% of all procedures were related to osteomyelitis. 8, 9 A study investigating the healthcare burden in Uganda reported that 3.5% of surgical procedures were for osteomyelitis, and 60% of these procedures were a sequestrectomy. 10 A retrospective study from a specialist orthopaedic hospital in Malawi reported that 6.7% of all orthopaedic procedures in children were for chronic osteomyelitis, the majority being a sequestrectomy. 11 Approximately 16% of children required a reconstructive procedure.
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Predisposing causes
Chronic osteomyelitis and poverty are closely related. Poor hygiene, frequent bacteraemias due to inadequate dental care and skin lesions, host deficiencies and poor healthcare provision are the major factors that predispose children to the condition. Malnutrition, anaemia, malaria and HIV infection are common in the tropics, and often co-exist. Environmental factors such as a hot climate and seasonal variations may also contribute to THE JOURNAL OF BONE AND JOINT SURGERY high levels of musculoskeletal sepsis. 12 Sickle cell disease is common in sub-Saharan Africa, and these patients are particularly susceptible to acute skeletal infections, often caused by a non-typhoid Salmonella species.
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Morbidity
Half of the world's population lack access to adequate primary healthcare, and two-thirds lack access to orthopaedic care. 15 Children who develop acute osteomyelitis and live in areas where health services are inadequate are more likely to present late, to go undiagnosed and to be mis-or untreated. This results in progression to chronic disease.
Children with chronic osteomyelitis suffer from physical, psychological and socioeconomic morbidity. Physical morbidity takes the form of general ill-health and locomotor problems. Function in the affected limb is often severely impaired by pain, joint stiffness, angular deformity, limblength discrepancy or lack of skeletal structural integrity. The child often lives with a chronic discharging sinus.
Physical problems lead to secondary problems. If the child is disabled by the condition, he or she may be unable to function normally within their family and social structure, and this can lead to economic problems for the family. Deformity, malodorous sinuses and disability may cause the child to become socially isolated. School attendance is often reduced owing to poor mobility and social stigmatism.
Classification
Classification systems for chronic osteomyelitis have been described by a number of authors. Waldvogel, Medoff and Swartz 16 classified osteomyelitis as being either acute or chronic according to duration, and according to the source of the infection (haematogenous, contiguous or secondary to vascular disease). This system is descriptive but is of little use in clinical management. Cierny, Mader and Penninck 17 described a system with four anatomical stages (1, medullary; 2, superficial; 3, localised; and 4, diffuse), and three host categories (A, no immunocompromise; B, one or more compromising factors; and C, severely compromised). This classification has been widely used in the literature, particularly in studies of adults with traumatic or iatrogenic osteomyelitis. We have not found it useful in children because it does not fit the clinical picture we see, and we have not found it useful in management. Thomas, Sanchez and Hoffman 18 described a modification of the Cierny classification 17 for use in children with chronic haematogenous osteomyelitis, but we have found no evidence of its use in other studies. This may be due to a lack of general awareness, as it was published in a non-Medline-indexed journal. The reliability of the classification has not been investigated or published.
The Beit Cure classification system was developed specifically for chronic haematogenous osteomyelitis in children 19 ( Fig. 1) . It was based on a review of a series of children with the condition, with the aim of developing a system that would be of prognostic value and aid surgical management. There are three main groups (A, B and C), the most common of which is the sequestrum/involucrum type (B), which has four subdivisions. This classification system also allows description of physeal damage to long bones. It has been shown to have good inter-and intra-observer reliability, 19 and in practice the authors have found that it is useful in planning surgical management.
Treatment
Children with chronic haematogenous osteomyelitis present with a broad spectrum of disease, from that which is relatively simple to treat and unlikely to leave the patient with any long-term disability to that which is complex and may leave the patient with a severe disability for the rest of their life. The basic aims of treatment are the eradication of infection, maintenance or restoration of the structural integrity of the skeleton, prevention or correction of deformity and return to adequate function.
It is generally accepted that surgery is the mainstay of treatment. Eradication of infection is dependent on the removal of the dead bone. When the pattern of disease is simple, this may be achieved relatively easily by sequestrectomy and curettage. In many sub-Saharan countries this may be performed by a non-orthopaedically trained doctor or a non-medically trained surgical officer. 20 However, in more complex patterns of disease where there is a pathological fracture, growth disruption, bone loss, joint involvement or severe soft-tissue damage, achieving this can be difficult, expensive and time-consuming, even for a specialist in a unit with appropriate facilities (Fig. 2) .
The results of four retrospective studies of children with osteomyelitis are summarised in Table I . 11, 18, 21, 22 The largest study to date in the literature is a retrospective study of 167 children treated at an orthopaedic tertiary referral hospital in Malawi. 11 In this study, 73% of children were successfully treated in a single admission with a median length of stay of 18 days; 16% required a second admission for further surgery to control infection and 16% required surgical reconstruction. Figure 2f -radiograph at two years after initial treatment was started, at which point the patient was free from infection and could walk without aids. THE JOURNAL OF BONE AND JOINT SURGERY Thomas et al 18 retrospectively studied 36 children who developed chronic haematogenous osteomyelitis after acute disease. Infection control was achieved by debridement and sequestrectomy. Cancellous or corticocancellous bone grafting was required in 20 patients, four had a fibular strut graft and two a fibula-to-tibia in situ cancellous bone graft.
Daoud and Saighi-Bouaouina 21 reported a series of 34 children with chronic haematogenous osteomyelitis in Algeria. They concluded that the status of the periosteum was of primary importance for predicting the evolution of the disease and planning treatment. Lauschke and Frey 22 performed a retrospective two-year follow-up study in Namibia of 49 children, 26 of whom had chronic disease, and were treated with debridement and sequestrectomy. Bony instability was present in 13 patients and treated by a splint or external fixator until an adequate involucrum had developed. A fibular graft was used in three. Poor results were recorded in six patients due to recurrent infection in four and leg-length discrepancy in two. There have been several other reported series of chronic osteomyelitis and its treatment; however, these included both children and adults, and traumatic as well as haematogenous osteomyelitis.
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Unsolved clinical problems
There are many unsolved problems in the treatment of chronic haematogenous osteomyelitis. Although there are several retrospective series reported from developed and developing countries, there are few reports of prospective or comparative research. Some of the unsolved questions that warrant further investigation by such studies are outlined below.
Timing of surgery
The timing of debridement and sequestrectomy is controversial. Most authors recommend waiting until a sufficient involucrum has formed before performing a sequestrectomy. The reasoning behind this is to minimise the risk of complications such as fracture, nonunion, deformity and segmental bone loss, which may occur if surgery is performed early. [26] [27] [28] Some reports have advocated delaying surgery on the grounds that the sequestrum may be absorbed while the involucrum is developing. 29, 30 Other authors recommend early sequestrectomy to eradicate infection and provide a better environment for the periosteum to respond, and to minimise damage to the surrounding soft tissues. 21, 23, 31 Thomas et al 18 observed in patients whose acute osteomyelitis became chronic that if an involucrum had not become visible on a plain radiograph by three months, it would not form, and recommended sequestrectomy at this stage to prevent further morbidity.
Either way, it is very important to preserve the periosteum, as this generates the involucrum that creates skeletal stability. Some patients who initially appear to have severe bone loss, with a massive structural deficit, can regenerate almost an entire diaphysis, provided infection is controlled and stability maintained. 32 In other cases the periosteum appears to die, fails to generate an involucrum, and surgical reconstruction is required. The cause of this is uncertain. It may be an ischaemic phenomenon or due to bacterial toxins.
Physeal damage
Damage to the physeal plate can lead to serious deformity, even when infection has been eradicated and structural integrity is maintained. A damaged physis with partial or complete growth arrest causes limb-length discrepancy or angular deformity, or both. The age at which this damage occurs is particularly important because of the remaining growth potential. Little is known about factors that may increase the risk of physeal damage. Potential factors include location and duration of disease, timing of surgery, bacteriology, and type of surgical intervention. Young infants are particularly susceptible as blood vessels still pass from the metaphysis into the epiphysis. The hip joint is also prone to damage in proximal femoral infection, as the metaphysis is intracapsular and can cause concurrent septic arthritis. It is important that the serious effects of physeal damage are appreciated. Eradication of infection in patients with disease adjacent to the physis should be an early priority in an attempt to prevent such damage.
What is the role of antibiotics?
Unlike in acute osteomyelitis, the role of systemic antibiotics in chronic osteomyelitis in children is uncertain. It is certainly a condition in which treatment with antibiotics alone is futile, because antibiotics cannot penetrate devitalised tissue. 33 In most cases patients present once the condition has been present for many months, and infection is persistent because of the presence of a sequestrum or sequestra. Antibiotics in the pre-operative stage of treatment may simply serve to promote resistance. Surgery to remove all devitalised tissue is the mainstay of treatment. There is probably a greater role for antibiotic use after surgery, but it is unknown whether routine post-operative systemic antibiotics improve the outcome following simple sequestrectomy and curettage. Satisfactory outcomes have been reported when surgical treatment was performed where antibiotics were unavailable, 34 and in series where antibiotics were used selectively.
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In cases where the involucrum is healthy, highly vascular and within a good soft-tissue envelope, antibiotics may be unnecessary provided the patient has a competent immune system. There are probably particular groups of patients in whom antibiotics are more likely to be beneficial. Patients with immune compromise may benefit from post-operative antibiotics, either until their immune status is restored or at least until the wounds have healed and the involucrum has matured. Another group are those who have an involucrum which appears sclerotic on the radiographs, with possible microsequestra within it (B-3 sequestrum with sclerotic involucrum; Fig. 1 ). The involucrum in these patients generally appears less healthy at surgery and they may benefit from antibiotics to suppress infection until the microsequestra within the involucrum are absorbed. The alternative is complete resection of any potentially diseased bone. This would leave a large segmental defect and reconstruction would be technically difficult and require prolonged treatment. The final group are those in whom reconstruction using bone graft is required (B-4 sequestrum without adequate structural involucrum; Fig. 1 ). There is at present no information in the literature upon which to base a treatment regimen for the use of systemic antibiotics in chronic haematogenous osteomyelitis in children. We are currently performing a prospective controlled study to evaluate the use of antibiotics in this situation. Antibiotics can also be delivered locally, most commonly using an antibiotic-loaded methylmethacrylate cement spacer or beads inserted after sequestrectomy. The rationale for this is that high concentrations of antibiotics are released locally, with the aim of sterilising the surgical field. Several series have reported the successful use of antibioticloaded beads or spacers inserted at the time of sequestrectomy, prior to bone grafting in children 35 and adults. 36, 40 The use of antibiotic-impregnated collagen 23 and plaster 41 implants have also been described. So far there have been no controlled trials of these techniques.
Which technique should be used for the reconstruction of bone defects?
When considering reconstruction in children, it is important to remember the potential of the periosteum to restore continuity. The limb may be protected with a splint or external fixator until this has been achieved. Formal reconstruction is required only when the periosteum has failed to regenerate sufficient involucrum. Several surgical options have been suggested for the reconstruction of defects in long bones. The main options are simple cancellous bone grafting, corticocancellous structural grafts, non-vascularised fibular strut grafts 42, 43 and vascularised structural grafts (usually the fibula), 44 or bone transport. 45 There are many factors to be considered when choosing which technique to use. The surrounding soft tissues need to be taken into account. The experience and skill of the surgeon is also important. For example, free vascularised fibular transfer is technically demanding and unlikely to be available in most developing countries. The size and site of the defect need to be considered. For example, a focal defect where the existing involucrum requires augmentation may be simply managed with cancellous bone grafting. Large segmental defects usually require an alternative technique. In a series of seven children with large tibial segmental defects Kucukkaya et al 45 reported excellent results using the Ilizarov technique. Others have reported satisfactory results using fibular strut grafts in selected cases, 18, 42, 43 and local vascularised fibular strut grafts for tibial defects. 44 The femur presents particular difficulties. Monolateral fixators and Ilizarov frames are not well tolerated. The fibula, which is most commonly used as a structural graft, is too weak and too small. There have been no comparative studies in children.
The timing and social impact of the treatment need to be taken into account. For example, the Ilizarov technique is effective for treating large defects but time-consuming for both the surgeon and the patient and their carers. In many developing countries patients may need to remain in hospital with a guardian for the duration of their treatment. This simply may not be an option because of the economic and social consequences for the patient and their family. In these circumstances a simpler, less time-consuming technique such as a non-vascularised fibular strut graft, which permits the patients to return home earlier, may be preferable.
How does HIV affect chronic osteomyelitis?
The incidence of HIV disease is high in most sub-Saharan countries. Intuitively, it would be expected that patients with a low CD4 count would be more susceptible to osteomyelitis and other musculoskeletal infections. There is some evidence that the overall burden of surgical sepsis has increased with the increasing prevalence of HIV, 46 but there are no published data to confirm that haematogenous osteomyelitis is more common in HIV-positive children. Aird et al 47 have recently shown that HIV disease may not be a contraindication to the fixation of open fractures. The implications of HIV disease with regard to treatment and prognosis, however, are unknown. The potential benefits of treatment with antiretroviral agents with regard to chronic haematogenous osteomyelitis are also unknown.
Chronic haematogenous osteomyelitis continues to affect many children throughout the world and it is a cause of severe morbidity and disability. Despite this, it is the subject of little current research. We hope that the Beit Cure classification will enable communication and comparative research. We have highlighted several areas where well-executed research, with collaboration between centres, could improve our understanding of the condition and its treatment.
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